Love v. Meyers

CourtDistrict Court, S.D. Illinois
DecidedMarch 29, 2022
Docket3:18-cv-02000
StatusUnknown

This text of Love v. Meyers (Love v. Meyers) is published on Counsel Stack Legal Research, covering District Court, S.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Love v. Meyers, (S.D. Ill. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF ILLINOIS

ABDUL LOVE,

Plaintiff,

v. Case No. 18-cv-2000-NJR

PERCY MYERS, LARUE LOVE, CHRISTOPHER THOMPSON, CHRISTINE BROWN, ROB JEFFREYS, and WEXFORD HEALTH SOURCES,

Defendants.

MEMORANDUM AND ORDER

ROSENSTENGEL, Chief Judge: Plaintiff Abdul Love, an inmate of the Illinois Department of Corrections (“IDOC”) who at all times relevant to this case was incarcerated at Pinckneyville Correctional Center (“Pinckneyville”), seeks monetary damages and injunctive relief for deprivations of his constitutional rights pursuant to 42 U.S.C. § 1983. In the Complaint, Love alleges that Defendants Percy Myers, Christine Brown, Larue Love, Christopher Thompson, and Wexford Health Sources, Inc. (hereinafter “Wexford”) were deliberately indifferent in treating his Crohn’s disease; he asserts claims against them under the Eighth Amendment. The case is now before the Court on summary judgment motions filed by Percy Myers and Wexford (Docs. 128, 129) and Christine Brown, Rob Jeffreys, Larue Love, and Christopher Thompson (Docs. 140, 141, 143). Love filed responses to the motions (Docs. 135, 136, 137, 144, respectively). FACTUAL AND PROCEDURAL BACKGROUND On October 19, 2018, Love filed his Complaint alleging deliberate indifference in the treatment of his Crohn’s disease (Docs. 1 and 8). He later amended his Complaint to add additional defendants (Doc. 64). Two claims were allowed to proceed: Count 1: Eighth Amendment deliberate indifference claim against Dr. Percy Myers, Larue Love, Christopher Thompson (in his individual and official capacities) and Christine Brown for failing to adequately treat Love’s Crohn’s disease.

Count 2: Eighth Amendment deliberate indifference claim against Wexford Health Sources, Inc. for hiring underqualified physicians.

(Doc. 63, pp. 3-4; Doc. 64). Love was also allowed to proceed against both Christopher Thompson, in his official capacity as warden of Pinckneyville, and John Baldwin, in his official capacity as IDOC Director, for purposes of implementing any injunctive relief awarded in the case (Doc. 8, p. 6; Doc. 63, p. 4). Both individuals are no longer employed at IDOC. On August 17, 2020, Rob Jeffreys (in his official capacity only) was substituted in place of John Baldwin (Doc. 122, p. 1 n. 1). Because Christopher Thompson is no longer the warden of Pinckneyville and Jeffreys has the authority to ensure Love receives any medical care awarded in this case, the official capacity claim against Christopher Thompson is DISMISSED (Doc. 141, p. 1 n. 1). A. Medical Care On May 18, 2018, Love transferred to Pinckneyville (Doc. 129-1, p. 6). He was first diagnosed with Crohn’s disease (hereinafter “Crohn’s”) in 2010 while at Menard Correctional Center (Id. at p. 15). According to Dr. Percy Myers, Crohn’s is an inflammatory bowel disease which currently has no cure (Doc. 129-2, p. 1). Patients with the disease are prescribed pain and symptom management plans to reduce flare-ups and keep the condition in remission (Id.). Love acknowledged that, because of his disease, he would experience times where he would have symptoms and that some medications may work at times and sometimes those medications will not work (Doc. 129-1, p. 41). Love previously saw a gastroenterologist prior to his transfer to Pinckneyville. In July

2017, he saw Dr. John Bozdech at Sarah D. Culbertson Hospital in Rushville, Illinois (Docs. 129-1, p. 16; 129-2, p. 1-2). At that time, Dr. Bozdech noted his last colonoscopy on April 21, 2017, showed a short segment of active colitis (Doc. 129-3, p. 53). Love was previously placed on mesalamine enemas, and Dr. Bozdech noted that he continued on mesalamine and budesonide with no symptoms (Id.). Dr. Bozdech’s plan in the event of a future flare-up was to continue with mesalamine enemas (Id.). If the treatment was not effective, Dr. Bozdech noted that Love “may” need to be prescribed “something like

azathioprine” (with the brand name of Imuran), an oral immunosuppressant (Id.; Doc. 129-1, p. 16). Dr. Myers testified in his affidavit that a typical mesalamine enema course lasts 4-5 weeks (Doc. 129-2, p. 2). While at Danville Correctional Center, Love began experiencing flare-ups (Doc. 129- 1, p. 16, 27). Love testified that he started another round of mesalamine enemas and budesonide and it worked well (Id. at p. 27). In December 2017 or January 2018, the enemas were discontinued, and he continued on the budesonide to keep his Crohn’s in remission

(Id.). On just the budesonide, Love testified that his symptoms began to reappear (Id. at p. 28). He began discussing with the medical director about implementing the immunosuppressant therapy Dr. Bozdech previously discussed, but after his blood work came back within normal parameters, the medical director decided not to start the Imuran (Id. at pp. 16, 28). To combat his continuing symptoms of blood, constipation, cramps, and diarrhea, in March or April 2018, Love was again prescribed mesalamine enemas and prednisone, an oral steroid (Id. at pp. 28-29; Doc. 129-3, p. 54). The prescription for the melamine enemas was for eight weeks (Doc. 129-3, p. 54). Prior to his transfer to Pinckneyville, Love testified that the regimen was not helping his Crohn’s symptoms (Id. at p. 29).

Upon transferring to Pinckneyville, he met with Dr. Myers in June 2018 and informed him that prior rounds of the mesalamine enemas had not worked, and Dr. Bozdech’s recommendation was to order a stronger immunosuppressant (Id. at p. 17). At the time, Love was still experiencing symptoms including bloody stool, painful cramps, episodes of diarrhea and constipation, as well as fecal incontinence (Id.). He explained his prior treatment history as well as his current condition (Id. at pp. 17-18, 29). Love testified that Dr. Myers wanted to continue with the mesalamine enemas until he could send Love to a specialist

(Id. at p. 18). From June until August 2018, Love experienced increasing symptoms. He testified to 14 or 15 bloody bowel movements a day as well as stomach cramps, bouts of constipation and/or diarrhea, and rectal burning (Doc. 129-1, p. 30). Love reported his increasing symptoms to Dr. Myers and his belief that his Crohn’s was becoming uncontrolled (Doc. 129- 2, p. 2). Dr. Myers referred Love to collegial review for a follow-up with a gastroenterologist (Id.). On August 23 and 25, 2018, Love refused his daily enemas (Doc. 129-3, pp. 64, 66).

On August 28, 2017, Love reported 15-20 bloody stools a day; the nurse practitioner ordered labs which would show evidence of his flare-ups, including decreased hemoglobin and hematocrit (Doc. 129-2, p. 2). According to Dr. Myers, a patient experiencing a flare-up would see a rise in the white blood cell count, sedimentation rate, and C-Reactive Protein numbers due to the triggered inflammatory process (Id.). But Love’s labs were all normal (Id.; Doc. 129-3, p. 61-63). As a result of the normal tests, Love was placed in the infirmary to monitor his symptoms (Doc. 129-2, p. 2; Doc. 129-1, p. 31). His bowel movements were monitored by nursing staff (Id.; Doc. 129-1, pp. 32-33). Love testified that he did not believe the tests were

accurate as nurses sometimes would not come back to check on his movements for up to an hour, and the blood would dissipate (Doc. 129-1, p. 33). He also believed that he should have been allowed to use a bedpan instead of the toilet to document his movements (Id. at p. 33, 46). Love testified that he believed some of the nurses did not properly document his movements or show up at all when he called (Id. at p. 35). Dr. Myers testified that no more than two bowel movements per day with very minimal blood were documented during Love’s stay in the infirmary (Doc. 129-2, p. 3).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Monell v. New York City Dept. of Social Servs.
436 U.S. 658 (Supreme Court, 1978)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Delapaz v. Richardson
634 F.3d 895 (Seventh Circuit, 2011)
Owens v. Hinsley
635 F.3d 950 (Seventh Circuit, 2011)
Arnett v. Webster
658 F.3d 742 (Seventh Circuit, 2011)
Donald F. Greeno v. George Daley
414 F.3d 645 (Seventh Circuit, 2005)
Gomez v. Randle
680 F.3d 859 (Seventh Circuit, 2012)
John Anderson v. Patrick Donahoe
699 F.3d 989 (Seventh Circuit, 2012)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Rodriguez v. Plymouth Ambulance Service
577 F.3d 816 (Seventh Circuit, 2009)
Hayes v. Snyder
546 F.3d 516 (Seventh Circuit, 2008)
Gayton v. McCoy
593 F.3d 610 (Seventh Circuit, 2010)
George v. Smith
507 F.3d 605 (Seventh Circuit, 2007)
Anne Spaine v. Community Contacts, Inc.
756 F.3d 542 (Seventh Circuit, 2014)
Joshua Bunn v. Khoury Enterprises, Inc.
753 F.3d 676 (Seventh Circuit, 2014)
Earnest D. Shields v. Illinois Department of Correct
746 F.3d 782 (Seventh Circuit, 2014)
John Doe v. Archdiocese of Milwaukee
743 F.3d 1101 (Seventh Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Love v. Meyers, Counsel Stack Legal Research, https://law.counselstack.com/opinion/love-v-meyers-ilsd-2022.